PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 13: Articles 6001-6500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. President Jiang Zemin on family planning and environmental protection.
  2. Pressures influence contraceptive use.
  3. Prevalence of induced abortion and family planning in Benin. [Prevalence des interruptions de grossesse et de la regulation des naissances au Benin.]
  4. Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception.
  5. Priorities and activities of the Slovak Society for Family Planning and Parenthood Education.
  6. Problems of young people calling the contraceptive advice line. [Problemy mladistvych na antikoncepcni poradni lince.]
  7. Problems related to the sex education and contraception of adolescents. [Probleme legate de educatia sexuala si contraceptiva a adolescentilor.]
  8. Proceedings: Emergency Contraception Workshop, December 9-10, 1997, Dhaka, Bangladesh.
  9. Progestin-androgen combination regimens for male contraception.
  10. Progestin-only hormonal contraception.
  11. Promote more civil-minded and happier families. Urban family planning programme.
  12. A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States)
  13. A prospective study of oral contraceptives and NIDDM among U.S. women.
  14. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer.
  15. Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine.
  16. Prosperous family development through national family planning movement 1997 / 1998. [Pembangunan keluarga sejahtera melalui gerakan kb nasional 1997 / 1998.]
  17. Protestants and family planning.
  18. Providers and consumers of commercial sector family planning services. A summary.
  19. Provision of family planning (FP) services by traditional birth attendants in Brong-Ahafo, Ghana.
  20. The provision of public-sector services by family planning agencies in 1995.
  21. Public scare has not deterred Finnish teenagers from using oral contraceptives [letter]
  22. Qualitative research on perceptions towards health services and contraceptives.
  23. Quality of care, client satisfaction, and contraceptive use in rural Bangladesh.
  24. Quality of care: the progress in the Bangladesh family planning program.
  25. The quality of family planning services in Douala, Cameroon. [Die Qualitat der Familienplanungsdienste in Douala, Kamerun.]
  26. The quality of family planning services in two low-income districts of Istanbul.
  27. Quality of family planning services.
  28. Quality services for Shanghai couples. Urban family planning programme.
  29. Raising awareness of emergency contraception.
  30. Randomised clinical trial to determine optimum initiation time of norgestrel-progestin only contraception in Eldoret teaching hospital, Kenya.
  31. A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive.
  32. A rapid procedure to assess awareness of, accessibility to, and utilization of health and family planning services.
  33. Rare case of the utero-vesical fistula caused by intrauterine contraceptive device.
  34. Re-evaluation of oral contraceptive classifications.
  35. Reaching men worldwide: lessons learned from family planning and communication projects, 1986-1996.
  36. Recent developments in the family planning program in China.
  37. Recommendations for updating selected practices in contraceptive use. Volume II.
  38. Recurrence of ectopic pregnancy: role of gynecological, obstetrical, contraceptive and smoking history. [La recidive de GEU: role des antecedents gyneco-obstetricaux, contraceptifs et du tabagisme.]
  39. Reduction in the size of a uterine leiomyoma following discontinuation of an estrogen-progestin contraceptive.
  40. Regional correlates of choice of contraceptive methods in Nigeria.
  41. The relationship between the quality of family planning services and client satisfaction.
  42. Reorienting community-based family planning services in Bangladesh: problems and prospects.
  43. Report of second situation analysis study of family planning services (delivery points) in Ghana.
  44. Reporting pill panic. A comparative analysis of media coverage of health scares about oral contraceptives.
  45. Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.
  46. Reproductive factors, oral contraceptive use, and risk of colorectal cancer.
  47. Reproductive health and family planning in Poland.
  48. Reproductive health in the countries of Eastern Europe. From abortion to modern effective contraception. European health policies. [La sante de la reproduction dans les pays de l'Europe de l'Est. De l'avortement a la contraception moderne efficace. Politiques europeennes de sante.]
  49. Reproductive health training for primary providers: a sourcebook for curriculum development. Module 1: Counseling clients for family planning / reproductive health services. Module 2: Educating clients and groups about family planning / reproductive health services.
  50. Reproductive health training for primary providers: a sourcebook for curriculum development. Module 3: Providing family planning services.
  51. Research closing in on birth control pill for men. Contraception (health)
  52. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
  53. A review of national family planning policies.
  54. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
  55. The rights of man. Contraception.
  56. Rising contraceptive use and age at marriage lower fertility levels in Morocco.
  57. Rising contraceptive use and age at marriage lower fertility levels in Morocco.
  58. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis.
  59. Risk of oral contraceptives and recency of market introduction [letter]
  60. Risks and benefits of adolescent contraception.
  61. The role of bias in observational studies on oral contraceptives [letter]
  62. The role of family planning programmes in contemporary fertility transitions.
  63. Romania: promotion of modern contraceptives and pharmacist services.
  64. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
  65. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
  66. Senate backs family-planning aid overseas.
  67. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills.
  68. Sex, pregnancy and contraception: a report of focus group discussions with adolescents.
  69. Sexual activity and contraceptive use among children entering out-of-home care.
  70. Sexual and reproductive health and family planning: enjoying and deciding without fear. [Salud sexual, reproductiva y planificacion familiar: gozar y decidir sin miedo.]
  71. Sexual behavior and contraceptive use: changes from 1975 to 1995 in college women.
  72. Sexual health contraceptive needs of adolescents with chronic conditions.
  73. Sexual self-acceptance, communication with partner, and contraceptive use among adolescent females: a longitudinal study.
  74. Sexuality and contraception in adolescents from Barcelona, Spain.
  75. Sexuality, reproduction, and family planning in women with schizophrenia.
  76. Sexually transmitted disease and family planning counselling of psychiatric patients in New Zealand.
  77. Shanghai premarital adolescent use of contraceptive methods and analysis of influencing factors.
  78. Should older women use the oral contraceptive pill?
  79. Should oral contraceptive users be screened for factor V Leiden? Oral contraceptives are not the only effective contraceptives [letter]
  80. Simultaneity in maternal-child health care utilization and contraceptive use: evidence from developing countries.
  81. Simultaneity in maternal-child health care utilization and contraceptive use: evidence from developing countries.
  82. Simultaneous determination of ethinylestradiol and levonorgestrel in oral contraceptives by derivative spectrophotometry.
  83. The situation analysis approach to assessing family planning and reproductive health services: a handbook.
  84. Situation analysis of LGU health centers for integrating RTI management within the Philippine FP / MCH program. Final report: USAID Contract No. DPE-C-00-90-0002-10, Strategies for Improving Family Planning Service Delivery.
  85. Situation analysis of the expansion of the role of auxiliary nurses in family planning service provision. Final report.
  86. A situation analysis of the Zimbabwe National Family Planning Council's youth centres: baseline assessment.
  87. Situation analysis: assessing family planning and reproductive health services. Quality of care.
  88. Skjeldestad misrepresents Norwegian oral contraceptive use [letter]
  89. Smoking and oral contraception.
  90. Social network associations with contraceptive use among Cameroonian women in voluntary associations.
  91. Some issues on estimation and demographic impact of contraceptive failure in Bangladesh.
  92. Spatial analysis of family planning in 1993 Costa Rica. [Analisis espacial de la planificacion familiar en Costa Rica 1993.]
  93. The spatial diffusion of contraception in Great-Britain and the origins of the fertility transition. [Diffusion spatiale de la contraception en Grande-Bretagne, a l'origine de la transition.]
  94. Spatial dimensions of family planning in Costa Rica: the value of geocoding demographic surveys. [Dimensiones espaciales de la planificación familiar en Costa Rica: el valor de codificar geográficamente las encuestas demográficas.]
  95. Speech on the occasion of national family planning launching ceremony.
  96. Stalemate over family planning assistance stalls foreign affairs bills. House conservatives insist on more restrictions despite Senate opposition, President's veto pledge.
  97. State-level variations in wanted and unwanted fertility provide a guide for India's family planning programmes.
  98. States acting to expand private insurance plans' contraceptive coverage.
  99. STDs in women attending family planning clinics: a case study in Addis Ababa.
  100. Sterilization for family planning in a Third World country.
  101. Sterilization in Finland: from eugenics to contraception.
  102. Stimulating men's support for long-term contraception: a campaign in Zimbabwe.
  103. The strategic approach to contraceptive introduction.
  104. Striking a feminist chord. Argentine women cheer first lady's family-planning views.
  105. In a strong voice. A proposal: training modules in sexual and reproductive rights. Module 6: The right to safe family planning. [En voz alta. Una propuesta: modulos para capacitacion en derechos sexuales y reproductivos. Modulo 6: Derecho a una planificacion familiar segura.]
  106. Struggle over international family planning heats up.
  107. A study of the influence of a gestodene-containing triphasic oral contraceptive on endometrial morphology.
  108. In sub-Saharan Africa, levels of knowledge and use of contraceptives are linked to media exposure.
  109. Surname reform and family planning: views from contributors.
  110. Survey of contraceptive services and extent of staff qualifications in family planning in primary care in Staffordshire.
  111. A survey of under-18 year old and 20-29 year old primigravidae delivered at the Port Moresby General Hospital: a comparative study of their sociodemographic and sexuality characteristics and contraceptive knowledge and experience.
  112. Survey research on reproductive preferences and contraceptive use in traditional Africa: are the responses meaningful?
  113. Sustainable development needs family planning: Mr. Wang Guoging.
  114. Synthesis and male contraceptive activity of C-substituted imidazoles [abstract]
  115. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk.
  116. Teenagers' views on the general practice consultation and provision of contraception.
  117. Testimony on oral contraceptives.
  118. Testing low-cost methodologies for gathering data on family planning / reproductive health clinic clients. INOPAL III. INPPARES / Peru in house project. Accounting Number 350.04037.
  119. Thermoregulation during exercise in women who are taking oral contraceptives.
  120. Third-generation oral contraceptives and venous thrombosis [letter]
  121. Third-generation oral contraceptives and venous thrombosis [letter]
  122. Third-generation oral contraceptives and venous thrombosis [letter]
  123. Third-generation oral contraceptives and venous thrombosis [letter]
  124. Third-generation oral contraceptives and venous thrombosis. Authors' reply [letter]
  125. A thought on the integration of poverty relief with family planning.
  126. Thromboembolic complications of oral contraceptive use (editorial) [Tromboemboliske komplikationer ved brug af p-piller.]
  127. Tobanese young generations' perception towards child value in Kotamadya Medan and Tarutung (and the input for the execution of family planning program)
  128. Today's contraceptive choices.
  129. Towards strengthening logistic support for MCH services and conventional contraceptives in Uttar Pradesh.
  130. Tradeoffs between precision and cost: a field test of rapid survey methods for family planning evaluation [abstract]
  131. Traditional values prevail as education and contraception enter rural Bangladesh.
  132. Traditional family planning in Bangladesh.
  133. Traditional family planning in Bangladesh. Summary report.
  134. Training needs assessment of district-level family planning and health program managers.
  135. Training needs assessment of thana, union and unit-level family planning and health personnel.
  136. Training private providers to improve access to quality contraceptive services.
  137. Treatment of bleeding problems associated with progestin-only contraceptives: survey results.
  138. Trends in demographic, family planning, and health indicators in Tanzania.
  139. Trends in demographic, family planning, and health indicators in Zambia, 1980-1996.
  140. Trends in oral contraceptive development and utilization: looking to the future.
  141. Trends in steroid contraceptive research.
  142. Trip report #P-3090. Training needs assessment for clinical family planning training of Indian Medical Association members in Uttar Pradesh. August 7 - December 31, 1997.
  143. The truth about contraceptive implants.
  144. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
  145. Two long-acting hormonal contraceptive options.
  146. Ultrasound characteristics of subdermally implanted Implanon contraceptive rods.
  147. An underage teenager who requests contraception.
  148. Unmet need for contraception in Vietnam: who needs what and when.
  149. Unmet need for family planning in a peri-urban community of Guatemala City.
  150. Unmet need for family planning in Nepal.
  151. Unmet need for family planning: a comparison of community-level studies in Guatemala, India and Zambia (preliminary findings)
  152. The unmet need for postpartum contraception: integration of LAM into programs to meet this need.
  153. Unmet requirements for contraceptive services.
  154. The unmet [need] for family planning in the United States.
  155. Unsuccessful contraception among patients seeking abortion on demand. [Neuspeshna kontratseptsiia sred patsientki, izvurshvashti abort po zhelanie.]
  156. Update on contraception.
  157. Urban adolescent females' views on the implant and contraceptive decision-making: a double paradox.
  158. Urban and rural family planning services in sub-Saharan Africa: does service quality really differ?
  159. Urinary tract infection and contraceptive method [editorial]
  160. The urological complications of contraception using intrauterine coils. [Urologicheskie oslozhneniia kontratseptsii vnutrimatochnymi spiraliami.]
  161. USA votes to release international family-planning funds.
  162. Use and effects of postcoital contraception. [Uso y efectos de la anticoncepcion poscoital.]
  163. The use of condoms with other contraceptive methods among young men and women.
  164. Use of contraception and knowledge of health technologies.
  165. Use of contraception in women who present for termination of pregnancy in inner London.
  166. The use of Geniia vaginal suppositories in patients employing hormonal contraceptives. [Prilozhenie na vaginalni globuli "Geniia" pri patsientki, upotrebiavashti khormonalni kontratseptivi.]
  167. Use of hormonal methods of birth control among sexually active adolescent girls.
  168. Use of hydrogen peroxide for vaginal contraception [letter]

     

  169. Use of low-dose oral contraceptives and stroke in young women.
  170. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata)
  171. Use of oral contraceptives and serum beta-carotene.
  172. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
  173. Vascular risk with third generation oral contraceptives. [Risque vasculaire des pilules contraceptives de troisieme generation.]
  174. Vesical calculus around an intra-uterine contraceptive device.
  175. Vietnam's population and family planning investments and savings (1979-2010) [Dau tu va tiet kiem tu chuong trinh dan so ke hoach hoa gia dinh o Viet Nam (1979-2010)]
  176. Vietnam: population and family planning investment remains low.
  177. Vikalp -- managing the family planning programme in the post-ICPD era: an experiment in Rajasthan, India.
  178. Welfare model of development and demographic transition: successful programmes on health, nutrition, family planning and development.
  179. What happens with IUDs indicated in family planning? [Que ocurre con los DIUs indicados en planificacion familiar?]
  180. What nurses should know about natural family planning.
  181. What's sex got to do with it? Challenges for incorporating sexuality into family planning programs.
  182. WHO Scientific Group Meeting on Cardiovascular Disease and Steroid Hormone Contraceptives. [Reunion du Groupe scientifique OMS sur les maladies cardio-vasculaires et les contraceptifs hormonaux steroidiens.]
  183. Who wants family planning? Three areas of Kaduna State, Nigeria.
  184. The whole truth about contraception: a guide to safe and effective choices.
  185. Why gender is a barrier to contraception advice.
  186. Why not use Nigeria's agricultural extension system to increase access to family planning?
  187. Why research on contraceptive user perspectives deserves public sector support: a free-market analysis.
  188. Why some men don't use condoms: male attitudes about condoms and other contraceptives.
  189. Women's literacy: the connection to health and family planning.
  190. Women's patterns of contraceptive use.
  191. Women's status and contraceptive innovation in urban Ethiopia.
  192. Working document on health and family planning indicators: a tool for results frameworks.
  193. The Working Group on the Evaluation of Family Planning Operations Research final report.
  194. Workshop on family planning in the era of AIDS. Nairobi, Kenya, 2-4 October, 1996.
  195. Workshop on promotion of reproductive health and family planning held.
  196. Youth centres in Kenya: evaluation of the Family Planning Association of Kenya programme.
  197. Zimbabwe: a family planning profile.
  198. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  199. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
  200. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
  201. Contraception and induced abortion. Study of a sample of 500 women. [Contraccezione e interruzione volontaria della gravidanza. Indagine conoscitiva su di un campione di 500 donne.]
  202. Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus.
  203. Contraceptive practice and attitudes in Sweden 1994.
  204. Contraceptive use and attitudes in Italy 1993.
  205. Contraceptive use and HIV infection in Kenyan family planning clinic attenders.
  206. The determinants of the duration of contraceptive use in China: a multilevel multinomial discrete-hazards modeling approach.
  207. The effect of contraception on fertility in the border region of Chiapas, Mexico. [Efecto de las practicas anticonceptivas sobre la fecundidad en la region fronteriza de Chiapas, Mexico.]
  208. The effect of oral contraceptive pills on markers of endometrial receptivity.
  209. The effects of contraceptive education on method use at first intercourse.
  210. Evaluating oral contraceptive use at 6 and 12 months.
  211. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
  212. Evidence-guided prescribing of combined oral contraceptives: consensus statement.
  213. Experiences of injectable contraceptive users in an urban setting.
  214. The fertility impact of alternative family planning distribution channels in Indonesia.
  215. A follow-up study of first trimester induced abortions at hospitals and family planning clinics in Sichuan province, China.
  216. The impact of oral contraception on chlamydial infection among patients with pelvic inflammatory disease.
  217. The impact of outreach on the continuity of contraceptive use in rural Bangladesh.
  218. The impact of the quality of family planning services on contraceptive use in Peru.
  219. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
  220. Interaction of oral contraceptive use with the effects of age, exercise habits and other cardiovascular risk modifiers on metabolic risk markers.
  221. Intrauterine contraceptive device-associated actinomycotic abscess and actinomyces detection on cervical smear.
  222. Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol / 75 micrograms gestodene and 30 micrograms ethinylestradiol / 75 micrograms gestodene, on lipid metabolism in an open randomized trial.
  223. Lactational amenorrhea as a family planning method. [La amenorrea de la lactancia como metodo de planificacion familiar.]
  224. The male versus female perspective on family planning: Kinshasa, Zaire.
  225. Maternal correlates of adolescent sexual and contraceptive behavior.
  226. Measuring compliance among oral contraceptive users.
  227. Mechanism of action of the intrauterine contraceptive device: evidence for a specific biochemical deficiency in the endometrium.
  228. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant.
  229. Nuptiality, fertility, use of contraception, and family policies in Uzbekistan.
  230. Postcoital contraception: who uses the "morning after pill"?
  231. Reduced serum cholecystokinin and increase in body fat during oral contraception.
  232. Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro-progestins.
  233. Results of a user satisfaction study carried out in women using Uniplant contraceptive implant.
  234. Stroke in users of low-dose oral contraceptives.
  235. A survey of hospital based out-of-hours emergency contraception service.
  236. Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil.
  237. Utilization patterns of oral contraceptives in UK general practice.
  238. Who gives advice about postpartum contraception?
  239. Zinc acetate and lyophilized aloe barbadensis as vaginal contraceptive.
  240. Multi-media campaigns, interpersonal contacts and contraceptive behaviour in southwest Nigeria.
  241. An assessment of the potential of health attendants for family planning and reproductive health expansion in Tanzania.
  242. Contraceptive logistics guidelines for refugee settings. Draft.
  243. Family Planning Program Monitoring and Evaluation System (FPPMES) User's manual version 2.1 for use with Lotus 123 release 5.0 for Windows. Estimating contraceptive prevalence and couple-years of protection from supply data.
  244. Family Planning Service Expansion and Technical Assistance project, SEATS II. Strategy for quality of care in family planning and reproductive health.
  245. On research: new contraceptive gel prevents pregnancy and STDs.
  246. Population: beyond contraceptive technology.
  247. Integration of RTI care into existing family planning services in Bangladesh: the possible and the practical.
  248. Performance monitoring for family planning and reproductive health programs: an approach paper.
  249. The impact of family planning and reproductive health on women's lives: a conceptual framework.
  250. Position statement on emergency contraception.
  251. Examining the increasing prevalence of traditional contraceptive methods in Honduras.
  252. Women's credit programs and family planning in rural Bangladesh.
  253. Contraceptive failure in Matlab, Bangladesh.
  254. Explaining the commitment of family planning fieldworkers in Bangladesh.
  255. Contraceptive prevalence in rural South Africa.
  256. Increasing contraceptive use in Bangladesh.
  257. Using electronic communications in family planning. [Utiliser les communications électroniques pour la planification familiale; El uso de las comunicaciones electrónicas en losprogramas de planificación familiar.]
  258. Family planning methods: new guidance./Methodes de planification familiale : nouvelles orientations./Metodos de planificacion familiar: nueva orientacion.
  259. China is top of contraception league.
  260. Contraceptive implants. Complete, understandable information is essential [letter]
  261. Contraceptive implants. High resolution untrasonography facilitates removal [letter]
  262. Contraceptive implants. Use is declining and may peak again around 1999 [letter]
  263. Contraceptive implants. Users lose out when misleading information limits choice.
  264. Effect of CSM's warning about safety of third generation oral contraceptives. Abortions increased by nearly 8 per cent in Norway [letter]
  265. Effect of CSM's warning about safety of third generation oral contraceptives. Contraceptive effectiveness may be being sacrificed for safety [letter]
  266. Effect of CSM's warning about safety of third generation oral contraceptives. General practitioners in England prescribed second generation pills instead [letter]
  267. Emergency contraception. Care must be taken to ascertain that woman is not already pregnant [letter]
  268. Emergency contraception. Use of the term is erroneous [letter]
  269. Guidelines for prescribing combined oral contraceptives [letter]
  270. Lactational amenorrhoea method for family planning. Provides high protection from pregnancy for the first six months after delivery.
  271. New Zealand doctors resist emergency contraception.
  272. Third generation oral contraception and venous thromboembolism. The published evidence confirms the Committee on Safety of Medicine's concerns.
  273. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study.
  274. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study.
  275. Third generation oral contraceptives. 12% of women stopped taking their pill immediately they heard CSM's warning [letter]
  276. Third generation oral contraceptives. CSM should rethink its approach for such announcements [letter]
  277. Third generation oral contraceptives. CSM's advice will harm women's health worldwide [letter]
  278. Third generation oral contraceptives. Full description of controls is needed in study [letter]
  279. Third generation oral contraceptives. How one clinic's practice conforms with CSM's advice [letter]
  280. Third generation oral contraceptives. Postmarketing surveillance does not catch all adverse events [letter]
  281. Third generation oral contraceptives. Study's results do not apply to norgestimate [letter]
  282. A 17-year-old mother seeking contraception.
  283. The 1995 Canadian Contraception Study.
  284. 1995 contraceptive social marketing statistics.
  285. 1995 national family planning, maternal and child health, and nutrition status report.
  286. 2nd Workshop on Family Planning in Catalonia and Baleares, Barcelona, May 16-17, 1996. [II Jornadas de Planificacion Familiar de Cataluna y Baleares, Barcelona, 16 y 17 de mayo de 1996.]
  287. 35 years with oral contraception: the Ghost of Pill Scare still rides] [editorial]
  288. Abortion and family planning in two northern communes of Vietnam.
  289. Abortion patients in 1994-1995: characteristics and contraceptive use.
  290. Abortion rate expected to soar -- contraceptives, not ban the answer.
  291. Access and atmosphere hold key to successful young people's family planning services.
  292. Access to genitourinary medicine services by women attending a family planning clinic.
  293. Achievements and challenges: Minister Peng on China's population situation and family planning programme.
  294. Adolescent access to contraception: a rights-based approach.
  295. Adolescent attitudes towards parental sex roles, family size, and birth control.
  296. Adolescent contraception and the just society.
  297. Adolescent contraception.
  298. Adolescent contraceptive behavior: the impact of the provider and the structure of clinic-based programs.
  299. Adolescents and the contraceptive pill: the impact of beliefs on intentions and use.
  300. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
  301. Adolescents' use of levonorgestrel implants for contraception.
  302. Adoption of family planning practices and its relationship with socio-economic characteristics: a changing profile in Seoni plateau (M.P.)
  303. Advances in the study of human chorionic gonadotropin-based birth control vaccines.
  304. Advantage 24 nonoxynol-9 product discussed at meeting. Contraception (spermicides)
  305. The advent of family planning as a social norm in Bangladesh: women's experiences.
  306. Advertising and PR for contraceptives.
  307. Africa takes a more male-friendly approach to family planning.
  308. African men and family planning: attitudes and behaviors. A review and analysis of the literature.
  309. Afro-Surinamese women in The Netherlands: sexual education, the initiation of sex, and contraceptive use.
  310. AMA's science reporters conference focuses on contraception and prevention of premature birth.
  311. Analysis of compliance with oral contraception in Spain.
  312. Analysis of the situation of the family planning program according to data from the National Survey of Family Planning, 1995. [Analisis de la situacion del programa de planificacion familiar segun datos de la Encuesta Nacional de Planificacion Familiar, 1995.]
  313. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.
  314. Antiprogestins: mechanism of action and contraceptive potential.
  315. APROFE: three decades of service. The history of family planning in Ecuador. [APROFE: tres decadas de servicio. Historia de la planificacion familiar en el Ecuador.]
  316. Assessing and improving family planning within reproductive health services.
  317. An assessment of health and family planning needs in rural Chittagong. Volume 1.
  318. Attitudes to current oral contraceptive use and future developments: the women's perspective.
  319. Audit of an emergency contraception service [letter]
  320. Availability of family planning services: developing a representative picture from Demographic and Health Surveys.
  321. Awareness of non-hormonal contraceptive (SAHELI) among subjects using MTP services [letter]
  322. Balochistan. Follow-up of recommendations of the Workshops on Village Based Family Planning Workers Quality Improvement.
  323. Bangladesh: family planning flourishes despite difficult economic circumstances.
  324. Barriers to contraceptive use in Kenya.
  325. Basal metabolic rate of women on the contraceptive pill.
  326. Basic indicators for reproductive health and family planning. [Indicadores básicos de salud reproductiva y planificación familiar.]
  327. Basic information -- family planning movement, prosperous family development. [Informasi dasar -- Gerakan KB, Pembangunan Kelvarga Sejahtera.]
  328. Benefits from family planning services.
  329. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy.
  330. Biochemical effects in women following one year's exposure to a new triphasic contraceptive. I. Chemistry profiles.
  331. Biochemical effects in women following one year's exposure to a new triphasic contraceptive. II. Coagulation profiles.
  332. Birth control discussed at priests' conference.
  333. Birth control spreads worldwide. [La regulation des naissances se generalise.]
  334. A birth duration fertility model with consideration of contraception factors.
  335. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
  336. Bone-sparing properties of oral contraceptives.
  337. Both contraceptive use and unplanned births are common in Ecuador.
  338. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
  339. Breast cancer and hormonal contraceptives: further results.
  340. Breast cancer and oral contraceptives -- the evidence so far [editorial]
  341. Bringing men and women together in family planning clinics.
  342. Budget stand-off's unexpected cost: more abortions. Study: Family planning cuts will cause 1.6 million more abortions each year. [Press release]
  343. Building a sustainable quality improvement system for family planning in Tanzania.
  344. Can girls also carry on the family lineage? Six contributors' views. Family planning forum.
  345. Cardiovascular disease and oral contraceptive use [editorial]
  346. Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening, 1985-88.
  347. Case studies in emergency contraception from six countries.
  348. Case-control study of oral contraceptive use and risk of breast cancer.
  349. Catholicism and demography. The church, world population, and birth control. [Le catholicisme et la demographie. Eglise, population mondiale, controle des naissances.]
  350. Causes of low contraceptive use in Tanzania: the case of the rural areas of Kondoa district.
  351. In the Central African Republic, contraceptive prevalence is low and few births are unwanted.
  352. The cervico-vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring.
  353. Changes in androgens during treatment with four low-dose contraceptives.
  354. Changes in patriarchal relations and male attitudes toward the adaptation of contraception: a case study of three Pare villages in the Kilimanjaro region of Tanzania.
  355. The changing pattern of contraception from 1975 to 2001: towards replacement level fertility in Sri Lanka.
  356. Characteristics of contraceptive acceptors in Luanda, Angola.
  357. Characteristics of family planning service utilization and source of supply in Bangladesh.
  358. Child mortality and fertility regulation behaviour in Bangladesh: implications for family planning programmes.
  359. Child survival and family planning.
  360. Child survival, health and family planning programmes and fertility.
  361. Chinese government White Paper on family planning.
  362. Chlamydia trachomatis screening in family planning centers: a review of cost / benefit evaluations in different countries.
  363. Choosing a permanent contraceptive. Does son preference matter?
  364. Client concepts unified in natural family planning. Elaboration of users' glossary concluded. [Se unifican conceptos de pacientes en planificacion familiar natural. Concluyo elaboracion de glosario de usuarias.]
  365. Clinic waste disposal in the family planning programme.
  366. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation.
  367. Coerced contraception? Moral and policy challenges of long-acting birth control.
  368. Coercion and quality in Indonesian family planning. A response to Anke Niehof.
  369. In Colombia, fertility decreases as contraceptive prevalence among women in union reaches 72%.
  370. Combination oral contraceptives and cardiovascular disease.
  371. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
  372. The combined oral contraceptive pill: what advice should we give when pills are missed? [letter]
  373. The combined oral contraceptive pill: what advice should we give when pills are missed? Authors' reply [letter]
  374. Community and contraceptive choice in rural Thailand: a case study of Nang Rong.
  375. Community Health Awareness Puppeteers (CHAPS): a programme for family planning and against AIDS.
  376. Community participation in family planning.
  377. Community-based delivery systems and social marketing of contraceptives.
  378. Community-based distribution and contraceptive social marketing.
  379. Community-based distribution of contraception: a pilot project in Khayelitsha, Cape Town.
  380. A community-based distribution strategy for family planning [editorial]
  381. Community-based family planning: theory and practice.
  382. Comparative costs of family planning services and hospital-based maternity care in Turkey.
  383. Comparative spermicidal performance of iodinated and non-iodinated contraceptive formulations of nonoxynol-9 co-precipitated with polyvinylpyrrolidone.
  384. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
  385. Comparative study on management of family planning programmes in selected African countries.
  386. A comparative study on the contraception efficacy and safety of the progesterone releasing contraceptive vaginal ring and the Copper T 380A IUD inserted during the lactation period.
  387. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
  388. A comparison of contraceptive habits and pregnancy outcome at 19 years of age in two cohorts of Swedish women born 1962 and 1972.
  389. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception.
  390. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
  391. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
  392. Compliance with contraceptives and other treatments.
  393. Comprehensive reproductive health and family planning training curriculum. Module 6: DMPA injectable contraceptive.
  394. Condom use increase in Norway appears related more to contraception than to disease prevention.
  395. Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive [letter]
  396. Congress again attacks international family planning.
  397. Congressional cuts threaten family planning programs.
  398. Consensus statement. Consensus development meeting 1995: combined oral contraceptives and cardiovascular disease. The Consensus Statement issued after the Second European Conference on Sex Steroids and Metabolism, Amsterdam, November 1995.
  399. A consumer survey of the availability of hormonal postcoital contraception in the North West Region.
  400. Consumer survey on preferred source of basic health care and family planning services, Philippines.
  401. Continuation rates among injectable contraceptive users.
  402. Continuation rates with a levonorgestrel-releasing contraceptive implant: prospective study in Belgium. [Continuite d'utilisation d'un implant contraceptif au levonorgestrel: etude prospective en Belgique.]
  403. Contraception and "natural" fertility in America.
  404. Contraception and clinical science. The place of women in reproductive technology.
  405. Contraception and religious practice in Bangladesh.
  406. Contraception and reproductive health care [editorial]
  407. Contraception and society. [Contraception et societe.]
  408. Contraception and STDs.

     

  409. Contraception and the late premenopause.
  410. Contraception and the under-16s: the legal issues.
  411. Contraception for the older woman.
  412. Contraception for women after childbirth.
  413. Contraception for women with health problems.
  414. Contraception guidance in women with pre-existing disturbances in carbohydrate metabolism.
  415. Contraception in the 1990s.
  416. Contraception in the United States: an overview and priorities for improvement.
  417. Contraception options shrinking -- US expert.
  418. Contraception with anti-progesterone.
  419. Contraception with subdermal levonorgestrel implants: a Tunisian study. [La contraception par les implants sous-cutanes de levonorgestrel: une etude tunisienne.]
  420. Contraception, pregnancy and lactation in women with epilepsy.
  421. Contraception, unintended pregnancies, and sexually transmitted diseases: why isn't a simple solution possible?
  422. Contraception.
  423. Contraception.
  424. Contraception. Methods, effectiveness, choice, contraindications, monitoring, risk. [Contraception. Methode, efficacite, choix, contre-indications, surveillance, risque.]
  425. Contraception: a strategic investment.
  426. Contraceptive choice, sexually transmitted diseases, HIV infection, and future fecundity.
  427. Contraceptive choices and experiences of sexuality: a comparison between sterilized and non-sterilized women in a metropolitan region of southeastern Brazil. [Opcoes contraceptivas e vivencias da sexualidade: comparacao entre mulheres esterilizadas e nao esterilizadas em regiao metropolitana do sudeste do Brasil.]
  428. Contraceptive choices: supporting effective use of methods.
  429. Contraceptive development and better family planning.
  430. Contraceptive device not likely to win US approval.
  431. Contraceptive discontinuation, failure, and switching behavior in the Philippines.
  432. Contraceptive distribution and logistics management information systems: a procedures manual.
  433. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
  434. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
  435. Contraceptive implants: long acting and provider dependent contraception raises concerns about freedom of choice.
  436. Contraceptive is the best development.
  437. Contraceptive knowledge, use, and sources.
  438. Contraceptive method and condom use among women at risk for HIV infection and other sexually transmitted diseases -- selected U.S. sites, 1993-1994.
  439. Contraceptive method mix menu: providing healthy choices for women.
  440. Contraceptive method's use and choice in Kerala and Uttar Pradesh: multinomial logit analysis of NFHS data.
  441. Contraceptive methods used in Istanbul and factors affecting method choice and continuation. [Istanbul'da kullanilan gebelikten korunma yontemleri, bu yontemlerin tercih ve kullanimini surdurmede etkili faktorler.]
  442. Contraceptive methods. 1. Technical presentation and contraindications. [Les moyens contraceptifs: 1. Presentation technique et contre-indications.]
  443. Contraceptive methods: do Hispanic adolescents and their family planning care providers think about contraceptive methods the same way?
  444. Contraceptive needs, complications, and new directions for research.
  445. Contraceptive patterns among women and men in Leon, Nicaragua.
  446. Contraceptive practice in Turkey.
  447. Contraceptive prevalence and adequacy of oral contraceptive use in Pelotas, Rio Grande do Sul, Brazil. [Prevalencia de uso de metodos contraceptivos e adequacao do uso de anticoncepcionais orais na cidade de Pelotas, Rio Grande do Sul, Brasil.]
  448. Contraceptive provision for the older woman.
  449. Contraceptive research and development.
  450. Contraceptive research and development: looking to the future.
  451. Contraceptive research and development: looking to the future.
  452. Contraceptive research and development: looking to the future. Public briefing, Philadelphia, Pa, May 29, 1996. Opening statement.
  453. Contraceptive services in the Indonesian family planning program: history, approach, achievements.
  454. Contraceptive social marketing.
  455. Contraceptive technology / reproductive health and training skills update curriculum. Volume 1. Trainer's materials.
  456. Contraceptive use among female adolescents.
  457. Contraceptive use and AIDS protective sexual behaviors in the era of AIDS.
  458. Contraceptive use and maternal-child health care utilization: a search for path of joint determination.
  459. Contraceptive use during lactational amenorrhea.
  460. Contraceptive use dynamics in Bangladesh.
  461. Contraceptive use dynamics in Indonesia.
  462. Contraceptive use dynamics in Turkey.
  463. Contraceptive use dynamics in Zimbabwe: discontinuation, switching, and failure.
  464. Contraceptive use dynamics seminar.
  465. Contraceptive use in India, 1992-93.
  466. Contraceptive use in women with heart disease. [Uso de contraceptivos em portadoras de cardiopatia.]
  467. Contraceptive use increases in Russia.
  468. Contraceptive use is most regular if teenagers have conventional lifestyles.
  469. Contraceptive use, and knowledge of postcoital contraception amongst HIV-infected women: a comparison with an HIV negative population.
  470. Contraceptive use.
  471. Contraceptive vaccines.
  472. Contraceptives hotline starts off hot.
  473. Contributions of Alexander D. Langmuir to the epidemiologic study of population change and family planning.
  474. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.
  475. Conversation and contraception in Nyanza province, Kenya.
  476. Correlates of oral contraceptive use in Italian women, 1991-93.
  477. Correlates of oral contraceptive use in two New England communities: 1981-1993.
  478. Cost of contraceptive supplies and services and cost-sharing.
  479. The cost-effectiveness of family planning service provision.
  480. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
  481. Coups d'etat and contraceptives: a political economy analysis of family planning in Haiti.
  482. The crisis in international family planning.
  483. Curriculum on family planning / reproductive health supervision and monitoring skills for MCH coordinators. Volume 1: Content outline.
  484. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
  485. Cytopathological and bacteriological findings in women using intrauterine contraceptive devices.
  486. Data collection of population and family planning. [Kumpulan data kependudukan dan keluarga berencana Indonesia.]
  487. Debate. What are the risks of third-generation oral contraceptives? Are third-generation oral contraceptives safe?
  488. Debate. What are the risks of third-generation oral contraceptives? Differences in venous thromboembolism-risk are related to causes other than product characteristics.
  489. Debate. What are the risks of third-generation oral contraceptives? Epidemiological disasters.
  490. Debate. What are the risks of third-generation oral contraceptives? Health policy and third-generation oral contraceptives.
  491. Debate. What are the risks of third-generation oral contraceptives? The public warnings on cardiovascular disease and third-generation oral contraceptives were not justified.
  492. Decline in cerebral thromboembolism among younger women after the introduction of low-dose oral contraceptives. A study of incidence during 1980-1995. [Fald v cerebral tromboemboli blandt yngre kvinder efter introduktion af lavdosis-p-piller. En incidensopgorelse for perioden 1980-1993.]
  493. A delayed starting schedule of oral contraception: the effect on the incidence of breakthrough bleeding and compliance in women.
  494. Delphi estimates on clients' perceptions of family planning services.
  495. Demand fulfillment and demand creation: a dual approach to family planning program development.
  496. Demographic and socio-economic determinants of contraceptive use in a low income community of Karachi.
  497. Demographic characteristics, socioeconomic profile and contraceptive behaviour in patients with abortion at Jimma Hospital, Ethiopia.
  498. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
  499. Depot medroxyprogesterone acetate contraception in women with medical problems.
  500. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.